Korean Journal of Occupational Health Nursing (한국직업건강간호학회지)

Korean Academic Society of Occupational Health Nursing (한국직업건강간호학회)
권호 표지

Effects of Obesity on the Physiological Levels of Adiponectin, Leptin and Diagnostic Indices of Metabolic Syndrome in Male Workers

남성 근로자의 비만이 adiponectin과 leptin의 생리적 농도와 대사증후군 진단지표에 미치는 영향

  • Heo, Kyung-Hwa (Korea Occupational Safety and Health Agency, Occupational Safety and Health Research Institute) ;
  • Won, Yong-Lim (Korea Occupational Safety and Health Agency, Occupational Safety and Health Research Institute) ;
  • Ko, Kyung-Sun (Korea Occupational Safety and Health Agency, Occupational Safety and Health Research Institute) ;
  • Kim, Ki-Woong (Korea Occupational Safety and Health Agency, Occupational Safety and Health Research Institute)
  • 허경화 (한국산업안전보건공단 산업안전보건연구원) ;
  • 원용림 (한국산업안전보건공단 산업안전보건연구원) ;
  • 고경선 (한국산업안전보건공단 산업안전보건연구원) ;
  • 김기웅 (한국산업안전보건공단 산업안전보건연구원)
  • Received : 2009.04.08
  • Accepted : 2009.05.20
  • Published : 2009.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to examine the effects of obesity on the physiological levels of adiponectin, leptin and components of metabolic syndrome (MS) in male workers, aged 30-40 years. Methods: Body mass index (BMI) was measured with Anthropometric equipment. Blood pressure and serum parameters were measured with an automatic digital sphygmomanometer and autochemical analyzer, respectively. Adiponectin and leptin were analysed by ELISA kits and MS was defined based on the NCEP-ATP III. Results: Body fat mass of waist and hip, systolic and diastolic blood pressure were significantly higher, as expected, in the BMI>25kg/$m^2$ in comparison with the $BMI{\leq}25kg/m^2$. While fasting glucose, insulin, HOMA-IR and leptin in the BMI>25kg/$m^2$ were also significantly higher compared with $BMI{\leq}25kg/m^2$, HDL-cholesterol and adiponectin were significantly higher in $BMI{\leq}25kg/m^2$. On multiple logistic regression analysis for the components of MS, exercise, adiponectin and leptin were an only independent factor for MS in non-obese male workers($BMI{\leq}25kg/m^2$) after adjustment for age, cigarette smoking and drinking habits. Conclusion: These results suggested that the obesity in men was associated with physiological levels of adiponectin and leptin contributing to feedback control of MS and that dysfunction and/or declination in feedback control system associated with changes in physiological levels of neurptrophics: adiponectin and leptin might ultimately induce MS.

Keywords

References

  1. 보건복지부 질병관리본부 (2007). 국민건강영양조사 제3기 조사결과 심층분석 연구 보고서.
  2. 보건복지가족부 질병관리본부 (2008). 2007 국민건강통계: 국민건강영양조사 제4기 1차년도.
  3. 이현진 (2007). 보건소 비만 프로그램을 통한 성인 여성의 체지방 변화에 따른 건강상태 및 식생활 비교. 단국대학원 석사논문.
  4. Alberti, K. G., Zimmert, P., & Shaw J. (2006). Metabolic syndrome: a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469-480. https://doi.org/10.1111/j.1464-5491.2006.01858.x
  5. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T., & Matsuzawa, Y. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79-83. https://doi.org/10.1006/bbrc.1999.0255
  6. Avramoglu, R. K., Basciano, H., & Adeli, K. (2006). Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368:1-19. https://doi.org/10.1016/j.cca.2005.12.026
  7. Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001). The adipocyte-secreted protein Acrp30 enhance hepatic insulin action. Nat Med 7:947-953. https://doi.org/10.1038/90992
  8. Cassis, L. A., Fettinger, M. J., Roe, A. L., Shenoy, U. R., & Howard, G. (1996). Characterization and regulation of angiotensin II receptors in rat adipose tissue. Angiotensin receptors in adipose tissue. Adv Exp Med Biol 396:39-47.
  9. Chen, H., Hansen, M. J., Jones, J. E., Vlahos, R., Bozinovski, S., Anderson, G. P., & Morris, M. J. (2007). Regulation of hypothalamic NPY by diet and smoking. Peptide 28:384-89. https://doi.org/10.1016/j.peptides.2006.07.034
  10. Cordero, A., Laclaustra, M., Leon, M., Casasnovas, J. A., Grima, A., Luengo, E., Ordonez, B., Bergua, C., Bes, M., Pascual, I., & Alegria, E. (2008). Comparison of serum lipid values in subjects with and without the metabolic syndrom. Am J Cardiol 102: 424-428. https://doi.org/10.1016/j.amjcard.2008.03.079
  11. DeFronzo, R, A., & Ferrannini, E. (1991). Obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14(3):173-194. https://doi.org/10.2337/diacare.14.3.173
  12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III).(2002). JAMA 28:2486-97.
  13. Fasshauer, M., Kralisch, S., Klier, M., Lossner, U., Bluher, M., Klein, J., & Paschke, R. (2003). Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301(4):1045-1050. https://doi.org/10.1016/S0006-291X(03)00090-1
  14. Fruhbeck, G., Nutr, R., & Salvador, L. (2004). Role of adipocytokines in metabolism and disease. Nutr Res 24:803-826. https://doi.org/10.1016/j.nutres.2004.07.002
  15. Gable, D. R., Hurel, S. J., & Humphries, S. .E. (2006). Adiponectin and its gene variants as risk factor for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 188:231-244. https://doi.org/10.1016/j.atherosclerosis.2006.02.010
  16. Kamohara, S., Burcelin, R., Halaas, J. L., Friedman, J. M., & Charron, M. J. (1997). Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377. https://doi.org/10.1038/38717
  17. Koebnick, C., Shaibi, G. Q., Kelly, L. A., Roberts, C. K., Lane, C. J., Toledo-Corral, C., Davis, J. N., Byrd-Williams, C., Weigensberg, M. J., & Goran, M. I. (2007). Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth. J Endocrinol Invest 30(7):RC13-6. https://doi.org/10.1007/BF03346344
  18. Koerner, A., Kratzsch, L., & Kiess, W. (2005). Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Practice & Research Clinical Endocrinology & Metabolism 19(4):525-546. https://doi.org/10.1016/j.beem.2005.07.008
  19. Krakoff, J., Funahashi T., Stehouwer, C. D., Schalkwijk, C. G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P. A., Hanson, R. L., Knowler, W. C., & Lindsay, R. S. (2003). Inflammatory markers, adiponectin, and risk of type 2 Diabetes Care 26: 1745-1751. https://doi.org/10.2337/diacare.26.6.1745
  20. Krauss, R. M., Winston, M., Fletcher, B. J., & Grundy, S. M. (1998). Obesity : impact on cardiovascular disease. Circulation 98(14):1472-1476. https://doi.org/10.1161/01.CIR.98.14.1472
  21. McCarty, M. F. (2009). Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Medical Hypotheses 72: 647-651. https://doi.org/10.1016/j.mehy.2008.12.031
  22. Pischon, T., Girman, C. J., Hotamisligil, G. S., Rifai, N., Hu, F. B., & Rimm, E. B. (2004). Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737. https://doi.org/10.1001/jama.291.14.1730
  23. Ruderman, M., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998). The metabolically obese, normal-weight individual revisited. Diabetes 47:699-713. https://doi.org/10.2337/diabetes.47.5.699
  24. Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y., & Funahashi, T. (2004). Adiponectin as a biomarker of the metabolic syndrome. Circ J 68:975-981. https://doi.org/10.1253/circj.68.975
  25. Sims, E. A.(2001). Are there persons who are obese, but metabolically healthy? Metabolism 50:1499-1504. https://doi.org/10.1053/meta.2001.27213
  26. Singhal, A., Farooqi, I. S., Cole, T. J., O'Rahilly, S., Fewtrell, M., Kattenhorm, M., Lucas, A., & Deanfield, J. (2002). Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation. 106(15):1919-1924. https://doi.org/10.1161/01.CIR.0000033219.24717.52
  27. Tilg, H., & Moschen, A. R. (2006). Adipocytokines : mediators linking adipose tissue, inflammation and immunity, Nature Reviews Immunology 6:772-783. https://doi.org/10.1038/nri1937
  28. Van Gaal, L. F., Mertens, L. L., & De Block, C. E. (2006). Mechanisms linking obesity with cardiovascular disease. Nature 444:875-880. https://doi.org/10.1038/nature05487
  29. Xita, N., Papassotiriou, I., Georgiou, I., Vounatsou, M., Margeli, A., & Tsatsoulis, A. (2007). The adiponectin-to-letin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Metab Clin Experimental 56:766-771. https://doi.org/10.1016/j.metabol.2007.01.008
  30. Zhou, Q., Wang, Z., Fu, P., Piao, J., Tian, Y., Xu, J., & Yang X. (2009). Comparison od adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Research and Clinical Practice 84:27-33. https://doi.org/10.1016/j.diabres.2008.12.019